Usefulness of GA-67 brain SPECT in patients with CNS malignant lymphoma

Annals of Nuclear Medicine

Volumn 10, Issue 4, 1996, Pages 391-394

  Fujii, Hirofumi ^a,b   Kosuda, Shigeru ^a   Suzuki, Kenzo ^a   Yorino, Hachiro ^a   Akita, Sakiko ^a   Negishi, Hitoshi ^a   Nakamura, Osamu ^a   Shitara, Nobuyuki ^a   Kubo, Atsushi ^b  

^a TOKYO METROPOLITAN KOMAGOME HOSPITAL   (Japan)

^b KEIO UNIVERSITY   (Japan)

Author keywords

brain tumor; gallium 67; malignant lymphoma; SPECT

Indexed keywords

GALLIUM 67; THALLIUM 201;

ADULT; AGED; ARTICLE; BRAIN LYMPHOMA; CANCER RADIOTHERAPY; CLINICAL ARTICLE; FEMALE; HUMAN; INTERMETHOD COMPARISON; MALE; PRIORITY JOURNAL; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; STEROID THERAPY;

EID: 0030477607     PISSN: 09147187     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03164799     Document Type: Article

References (20)

1. 67Ga-citrate. J Nucl Med 10: 103-105, 1969.
2. Turner DA, Fordham EW, Ali A, Slayton RE. Gallium-67 imaging in the management of Hodgkin's disease and other malignant lymphomas. Seminars in Nuclear Medicine 8: 205-218, 1978.
3. Israel'O, Front D, Lam M, Ben-Haim S, Kleinhaus U, Ben-Shachar M, et al. Gallium 67 imaging in monitoring lymphoma response to treatment. Cancer 61: 2439-2443, 1988.
4. Nedellec G, Lioure B, Bussy E, Carlioz R, Gaillard JF, Auzanneau G. Evaluation of residual masses after lymphoma treatment: the contribution of gallium-67 tomoscintigraphy. Nouvelle Revue Francaise d Hematologie 32: 187-190, 1990.
5. Harwood SJ, Carroll RG, Anderson M, Friedman BI, Zangara LM, Brunette AK, et al. SPECT gallium scanning for lymphoma and infection. Clin Nucl Med 12: 694-702, 1987.
6. Tumeh SS, Rosenthal DS, Kaplan WD, English RJ, Holman BL. Lymphoma: evaluation with Ga-67 SPECT. Radiology 164: 111-114, 1987.
7. 67Ga-citrate - detection of involved lesions in malignant lymphoma. KAKU IGAKU (Jpn J Nucl Med) 18: 1343-1351, 1981.
8. Zidar BL, Adatepe M, Hryschko F, Hartsock RJ, Kessler L, Lyons TA. Diagnosis of non-Hodgkin's lymphoma intracerebral mass lesions. Usefulness of Tc-99m pertechnetate and Ga-67 citrate brain scans. Clin Nucl Med 7: 497-501, 1982.
9. Kosuda S, Aoki S, Suzuki K, Nakamura H, Nakamura O, Shidara N. Primary malignant lymphoma of the central nervous system by Ga-67 and Tl-201 brain SPECT. Clin Nucl Med 17: 961-964, 1992.
10. Roman-Goldstein SM, Goldman DL, Howieson J, Belkin R, Neuwelt EA. MR of primary CNS lymphoma in immunologically normal patients. AJNR 13: 1207-1213, 1992.
11. Eby NL, Grufferman S, Flannelly CM, Schold SC, Vogel FS, Burger PC. Increasing incidence of primary brain lymphoma in the US. Cancer 62: 2461-2465, 1988.
12. Petito CK, Cho E-S, Lemann W, Navia BA, Price RW. Neuropathology of acquired immunodeficiency syndrome (AIDS): an autopsy review. J Neuropathol Exp Neurol 45: 635-646, 1986.
13. Lee Y-Y, Bruner JM, Tassel PV, Libshitz HI. Primary central nervous system lymphoma: CT and pathologic correlation. AJR 147: 747-752, 1986.
14. Kosuda S, Fujii H, Aoki S, Suzuki K, Tanaka Y, Nakamura O, et al. Reassessment of quantitative thallium-201 brain SPECT for miscellaneous brain tumors. Ann Nucl Med 7: 257-263, 1993.
15. Osborn AG. Diagnostic Neuroradiology. 1st ed. St. Louis: Mosby, 1994.
16. Palacios E, Gorelick PB, Gonzalez CF, Fine M. Malignant lymphoma of the nervous system. J Comput Assist Tomogr 6: 689-701, 1982.
17. Whelan MA, Kricheff II. Intracranial lymphoma. Semin Roentgenol 19: 91-99, 1984.
18. Schwaighofer BW, Hesselink JR, Press GA, Wolf RL, Healy ME, Berthoty DP. Primary intracranial CNS lymphoma: MR manifestations. AJNR 10: 725-729, 1989.
19. Kaplan WD, Takvorian T, Morris JH, Rumbaugh CL, Connolly BT, Atkins HL. Thallium-201 brain tumor imaging: a comparative study with pathologic correlation. J Nucl Med 28: 47-52, 1987.
20. 4 in the brain scintigraphy by the conventional rectilinear scanner. KAKU IGAKU (Jpn J Nucl Med) 12: 221-233, 1975.